other material
confidence high
sentiment neutral
materiality 0.50
Xenetic Biosciences enters $4M ATM equity offering with H.C. Wainwright
Xenetic Biosciences, Inc.
- Entered ATM Agreement with H.C. Wainwright as exclusive agent to sell up to $4M of common stock.
- Shares sold at-the-market on Nasdaq; Wainwright receives 3% commission on gross proceeds.
- Company has no obligation to sell any shares and may suspend or terminate the agreement.
- Agreement effective November 19, 2021; filed as Exhibit 1.1 to the 8-K.